{"transactions":[{"id":1609465,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2024-02-29T21:11:11.000Z","date":"2024-02-27","kind":"sale","planned":false,"acquired":false,"shares":4930,"price":6.1,"value":30073.0,"ownership":{"direct":true},"balance_after":319128,"source":{"system":"sec-edgar","filing":"0001600620-24-000028","document":"wk-form4_1709241050.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062024000028/wk-form4_1709241050.xml","form_type":"4"}},{"id":1624613,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2024-02-22T21:35:13.000Z","date":"2024-02-20","kind":"sale","planned":false,"acquired":false,"shares":25146,"price":5.48,"value":137800.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs granted on August 1, 2022 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 2,500 shares of common stock were acquired on May 31, 2023 and 2,430 shares of common stock were acquired on November 30, 2023."}],"balance_after":324058,"source":{"system":"sec-edgar","filing":"0001600620-24-000022","document":"wk-form4_1708637692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062024000022/wk-form4_1708637692.xml","form_type":"4"}},{"id":1968227,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2023-03-06T21:28:18.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":191462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of Restricted Stock Units (RSUs) payable solely in common stock of the Issuer that vest in three (3) equal annual installments on the first, second and third anniversary of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person has reported prior awards of RSUs in Table II of Form 4. The total reported in Column 5 includes the 191,462 newly awarded RSUs and 152,812 RSUs previously reported in Table II, which vests in three (3) equal annual installments beginning August 1, 2023."}],"balance_after":344274,"source":{"system":"sec-edgar","filing":"0001628280-23-006527","document":"wf-form4_167813808294932.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828023006527/wf-form4_167813808294932.xml","form_type":"4"}},{"id":2198827,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research and Development"}}],"security":"Restricted Stock Units","published_at":"2022-08-01T20:13:47.000Z","date":"2022-08-01","kind":"grant","acquired":true,"shares":152812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning August 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning August 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning August 1, 2023."}],"balance_after":152812,"derivative":{"underlying":"Common Shares","underlying_shares":152812},"source":{"system":"sec-edgar","filing":"0001628280-22-019950","document":"wf-form4_165938480733710.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828022019950/wf-form4_165938480733710.xml","form_type":"4"}},{"id":2198826,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research and Development"}}],"security":"Stock Option (right to buy)","published_at":"2022-08-01T20:13:47.000Z","date":"2022-08-01","kind":"grant","acquired":true,"shares":256892,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter."}],"balance_after":256892,"derivative":{"exercise_price":8.18,"expiration_date":"2032-08-01","underlying":"Common Stock","underlying_shares":256892},"source":{"system":"sec-edgar","filing":"0001628280-22-019950","document":"wf-form4_165938480733710.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828022019950/wf-form4_165938480733710.xml","form_type":"4"}},{"id":2722859,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:15:36.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":76488,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Transaction Agreement, one-third of these share options vested and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration, and the remaining two-thirds were converted into an option to acquire Jazz ordinary shares (with any performance goals deemed fully satisfied), half of which will vest on March 2, 2022 and half of which will vest on March 2, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Transaction Agreement, one-third of these share options vested and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration, and the remaining two-thirds were converted into an option to acquire Jazz ordinary shares (with any performance goals deemed fully satisfied), half of which will vest on March 2, 2022 and half of which will vest on March 2, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":76488},"source":{"system":"sec-edgar","filing":"0000899243-21-018663","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018663/doc4.xml","form_type":"4"}},{"id":2722858,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:15:36.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":47808,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Transaction Agreement, one-third of these share options vested and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration, and the remaining two-thirds were converted into an option to acquire Jazz ordinary shares (with any performance goals deemed fully satisfied), half of which will vest on March 2, 2022 and half of which will vest on March 2, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Transaction Agreement, one-third of these share options vested and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration, and the remaining two-thirds were converted into an option to acquire Jazz ordinary shares (with any performance goals deemed fully satisfied), half of which will vest on March 2, 2022 and half of which will vest on March 2, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":47808},"source":{"system":"sec-edgar","filing":"0000899243-21-018663","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018663/doc4.xml","form_type":"4"}},{"id":2722857,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:15:36.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":93024,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":93024},"source":{"system":"sec-edgar","filing":"0000899243-21-018663","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018663/doc4.xml","form_type":"4"}},{"id":2722856,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:15:36.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":155028,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":155028},"source":{"system":"sec-edgar","filing":"0000899243-21-018663","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018663/doc4.xml","form_type":"4"}},{"id":2722855,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:15:36.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":13728,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":13728},"source":{"system":"sec-edgar","filing":"0000899243-21-018663","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018663/doc4.xml","form_type":"4"}},{"id":2722854,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:15:36.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":91584,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":91584},"source":{"system":"sec-edgar","filing":"0000899243-21-018663","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018663/doc4.xml","form_type":"4"}},{"id":2722853,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:15:36.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":8436,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":8436},"source":{"system":"sec-edgar","filing":"0000899243-21-018663","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018663/doc4.xml","form_type":"4"}},{"id":2722852,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:15:36.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":12156,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":12156},"source":{"system":"sec-edgar","filing":"0000899243-21-018663","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018663/doc4.xml","form_type":"4"}},{"id":2722851,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:15:36.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":48252,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."}],"balance_after":0,"derivative":{"exercise_price":14.3342,"expiration_date":"2029-03-01","underlying":"Ordinary Shares","underlying_shares":48252},"source":{"system":"sec-edgar","filing":"0000899243-21-018663","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018663/doc4.xml","form_type":"4"}},{"id":2722850,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:15:36.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":55536,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."}],"balance_after":0,"derivative":{"exercise_price":9.6092,"expiration_date":"2028-02-26","underlying":"Ordinary Shares","underlying_shares":55536},"source":{"system":"sec-edgar","filing":"0000899243-21-018663","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018663/doc4.xml","form_type":"4"}},{"id":2722849,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:15:36.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":150444,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."}],"balance_after":0,"derivative":{"exercise_price":8.6433,"expiration_date":"2027-05-18","underlying":"Ordinary Shares","underlying_shares":150444},"source":{"system":"sec-edgar","filing":"0000899243-21-018663","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018663/doc4.xml","form_type":"4"}},{"id":2722848,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-07T16:15:36.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":92412,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 5, 2021, Jazz Pharmaceuticals Public Limited Company, a public limited company incorporated in the Republic of Ireland (\"Jazz\"), Jazz Pharmaceuticals UK Holdings Limited, a private limited company incorporated in England and Wales and an indirect wholly owned subsidiary of Jazz (\"Bidco\") and the DR Nominee (as defined in the Transaction Agreement) acquired all outstanding ordinary shares, par value British Pound Sterling 0.001 per share, of GW Pharmaceuticals plc, a public limited company incorporated in England and Wales (the \"Company\"), by means of a scheme of arrangement under Part 26 of the UK Companies Act 2006 (the \"Scheme of Arrangement\") (continued in footnote 2)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Scheme of Arrangement, Scheme Shareholders (as defined in the Scheme of Arrangement) became entitled to receive for each Scheme Share (as defined in the Scheme of Arrangement) held by them an amount equal to $16.66 2/3 in cash plus 0.010030 ordinary shares, nominal value $0.0001 per share, of Jazz (\"Jazz ordinary shares\"). The transaction is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on March 15, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-018663","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018663/doc4.xml","form_type":"4"}},{"id":2767850,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-03-30T20:00:11.000Z","date":"2021-03-26","kind":"sale","acquired":false,"shares":3060,"price":18.1,"value":55386.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represented by American Depositary Shares of the Issuer (\"ADS\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a price per ordinary share converted from price per ADS."}],"balance_after":92412,"source":{"system":"sec-edgar","filing":"0000899243-21-014010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321014010/doc4.xml","form_type":"4"}},{"id":2819575,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Share Options","published_at":"2021-03-02T21:31:05.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":6864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of March 1, 2021."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0.0014,"exercise_date":"2021-03-01","expiration_date":"2021-03-01","underlying":"Ordinary Shares","underlying_shares":6864},"source":{"system":"sec-edgar","filing":"0000899243-21-009218","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321009218/doc4.xml","form_type":"4"}},{"id":2819574,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Share Options","published_at":"2021-03-02T21:31:05.000Z","date":"2021-02-26","kind":"exercise","acquired":false,"shares":8448,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of February 26, 2021."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0.0014,"exercise_date":"2021-02-26","expiration_date":"2021-02-26","underlying":"Ordinary Shares","underlying_shares":8448},"source":{"system":"sec-edgar","filing":"0000899243-21-009218","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321009218/doc4.xml","form_type":"4"}},{"id":2819573,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Share Options","published_at":"2021-03-02T21:31:05.000Z","date":"2021-02-26","kind":"exercise","acquired":false,"shares":112548,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of February 26, 2021."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0.0014,"exercise_date":"2021-02-26","expiration_date":"2021-02-26","underlying":"Ordinary Shares","underlying_shares":112548},"source":{"system":"sec-edgar","filing":"0000899243-21-009218","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321009218/doc4.xml","form_type":"4"}},{"id":2819572,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:31:05.000Z","date":"2021-03-01","kind":"tax_withholding","acquired":false,"shares":2712,"price":17.85,"value":48409.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Withhold to cover vested RSU style share options."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADS."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":95472,"source":{"system":"sec-edgar","filing":"0000899243-21-009218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321009218/doc4.xml","form_type":"4"}},{"id":2819571,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:31:05.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":6864,"price":0.0014,"value":9.6096,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of February 26, 2021."}],"balance_after":98184,"source":{"system":"sec-edgar","filing":"0000899243-21-009218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321009218/doc4.xml","form_type":"4"}},{"id":2819570,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:31:05.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":3325,"price":17.9,"value":59517.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Withhold to cover vested RSU style share options."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADS."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":91320,"source":{"system":"sec-edgar","filing":"0000899243-21-009218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321009218/doc4.xml","form_type":"4"}},{"id":2819569,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:31:05.000Z","date":"2021-02-26","kind":"exercise","acquired":true,"shares":8448,"price":0.0014,"value":11.8272,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of February 26, 2021."}],"balance_after":94645,"source":{"system":"sec-edgar","filing":"0000899243-21-009218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321009218/doc4.xml","form_type":"4"}},{"id":2819568,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:31:05.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":44291,"price":17.9,"value":792808.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Withhold to cover vested RSU style share options."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADS."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":86197,"source":{"system":"sec-edgar","filing":"0000899243-21-009218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321009218/doc4.xml","form_type":"4"}},{"id":2819567,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:31:05.000Z","date":"2021-02-26","kind":"exercise","acquired":true,"shares":112548,"price":0.0014,"value":157.5672,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of February 26, 2021."}],"balance_after":130488,"source":{"system":"sec-edgar","filing":"0000899243-21-009218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321009218/doc4.xml","form_type":"4"}},{"id":2835519,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Share Options","published_at":"2021-02-24T18:57:00.000Z","date":"2021-02-22","kind":"grant","acquired":true,"shares":47808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.41 U.S. Dollars as of February 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These share options will vest in four equal annual installments beginning on February 22, 2022 and be automatically exercised upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These share options will vest in four equal annual installments beginning on February 22, 2022 and be automatically exercised upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."}],"balance_after":47808,"derivative":{"exercise_price":0.0014,"underlying":"Ordinary Shares","underlying_shares":47808},"source":{"system":"sec-edgar","filing":"0000899243-21-008103","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321008103/doc4.xml","form_type":"4"}},{"id":2835518,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Share Options","published_at":"2021-02-24T18:57:00.000Z","date":"2021-02-22","kind":"grant","acquired":true,"shares":76488,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on February 22, 2024 if certain performance conditions are satisfied."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.41 U.S. Dollars as of February 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on February 22, 2024 if certain performance conditions are satisfied."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on February 22, 2024 if certain performance conditions are satisfied."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."}],"balance_after":76488,"derivative":{"exercise_price":0.0014,"underlying":"Ordinary Shares","underlying_shares":76488},"source":{"system":"sec-edgar","filing":"0000899243-21-008103","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321008103/doc4.xml","form_type":"4"}},{"id":2902036,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-01-20T20:00:15.000Z","date":"2021-01-19","kind":"sale","acquired":false,"shares":6000,"price":11.67,"value":70020.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represented by American Depositary Shares of the Issuer (\"ADSs\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a price per ordinary share converted from price per ADS."}],"balance_after":17940,"source":{"system":"sec-edgar","filing":"0000899243-21-002560","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321002560/doc4.xml","form_type":"4"}},{"id":2965982,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2020-11-25T20:00:08.000Z","date":"2020-11-24","kind":"sale","acquired":false,"shares":12000,"price":10.5,"value":126000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represented by American Depositary Shares of the Issuer (\"ADSs\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a price per ordinary share converted from price per ADS."}],"balance_after":23940,"source":{"system":"sec-edgar","filing":"0000899243-20-032225","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320032225/doc4.xml","form_type":"4"}},{"id":2980956,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2020-11-13T20:00:10.000Z","date":"2020-11-11","kind":"sale","acquired":false,"shares":6000,"price":10,"value":60000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represented by American Depositary Shares of the Issuer (\"ADSs\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a price per ordinary share converted from price per ADS."}],"balance_after":35940,"source":{"system":"sec-edgar","filing":"0000899243-20-031062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320031062/doc4.xml","form_type":"4"}},{"id":2990964,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2020-11-05T20:00:12.000Z","date":"2020-11-04","kind":"sale","acquired":false,"shares":6000,"price":9.17,"value":55020.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represented by American Depositary Shares of the Issuer (\"ADSs\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a price per ordinary share converted from price per ADS."}],"balance_after":41940,"source":{"system":"sec-edgar","filing":"0000899243-20-030504","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320030504/doc4.xml","form_type":"4"}},{"id":3065781,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2020-08-06T20:01:05.000Z","date":"2020-08-04","kind":"sale","acquired":false,"shares":6000,"price":11.11,"value":66660.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represented by American Depositary Shares of the Issuer (\"ADSs\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a price per ordinary share converted from price per ADS."}],"balance_after":47940,"source":{"system":"sec-edgar","filing":"0000899243-20-021685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320021685/doc4.xml","form_type":"4"}},{"id":3077655,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2020-07-22T20:00:33.000Z","date":"2020-07-20","kind":"sale","acquired":false,"shares":6000,"price":11.42,"value":68520.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represented by American Depositary Shares of the Issuer (\"ADS\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":53940,"source":{"system":"sec-edgar","filing":"0000899243-20-020102","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320020102/doc4.xml","form_type":"4"}},{"id":3104157,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2020-06-19T20:02:00.000Z","date":"2020-06-17","kind":"sale","acquired":false,"shares":18000,"price":10.35,"value":186300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represented by American Depositary Shares of the Issuer (\"ADSs\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a price per ordinary share converted from price per ADS."}],"balance_after":59940,"source":{"system":"sec-edgar","filing":"0000899243-20-017299","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320017299/doc4.xml","form_type":"4"}},{"id":3104156,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2020-06-19T20:02:00.000Z","date":"2019-05-15","kind":"sale","acquired":false,"shares":4296,"price":14.63,"value":62850.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2019. Inadvertent late filing."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represented by American Depositary Shares of the Issuer (\"ADSs\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a price per ordinary share converted from price per ADS."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Due to an administrative error, the Reporting Person's Form 3 filed with the SEC on October 1, 2018 overstated the Reporting Person's ownership of the Issuer's ordinary shares by 4,440 shares (370 ADSs).  These shares have been excluded from Column 5."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Also reflects an adjustment to total holdings to exclude twelve shares incorrectly included in prior reports."}],"balance_after":77940,"source":{"system":"sec-edgar","filing":"0000899243-20-017299","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320017299/doc4.xml","form_type":"4"}},{"id":3118516,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Share Options","published_at":"2020-06-08T20:01:01.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":93024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.26 U.S. Dollars as of June 4, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These share options will vest in four equal annual installments beginning on June 4, 2021 and be automatically exercised upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These share options will vest in four equal annual installments beginning on June 4, 2021 and be automatically exercised upon vesting."}],"balance_after":93024,"derivative":{"exercise_price":0.0013,"underlying":"Ordinary Shares","underlying_shares":93024},"source":{"system":"sec-edgar","filing":"0000899243-20-015690","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320015690/doc4.xml","form_type":"4"}},{"id":3118515,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Share Options","published_at":"2020-06-08T20:01:01.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":155028,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on June 4, 2023 if certain performance conditions are satisfied."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.26 U.S. Dollars as of June 4, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on June 4, 2023 if certain performance conditions are satisfied."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on June 4, 2023 if certain performance conditions are satisfied."}],"balance_after":155028,"derivative":{"exercise_price":0.0013,"underlying":"Ordinary Shares","underlying_shares":155028},"source":{"system":"sec-edgar","filing":"0000899243-20-015690","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320015690/doc4.xml","form_type":"4"}},{"id":3140656,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2020-05-20T20:02:34.000Z","date":"2020-05-18","kind":"exercise","acquired":false,"shares":12144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.22 U.S. Dollars as of May 18, 2020."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0.0012,"exercise_date":"2020-05-18","expiration_date":"2020-05-18","underlying":"Ordinary Shares","underlying_shares":12144},"source":{"system":"sec-edgar","filing":"0000899243-20-013769","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320013769/doc4.xml","form_type":"4"}},{"id":3140655,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2020-05-20T20:02:34.000Z","date":"2020-05-18","kind":"exercise","acquired":false,"shares":121476,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.22 U.S. Dollars as of May 18, 2020."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0.0012,"exercise_date":"2020-05-18","expiration_date":"2020-05-18","underlying":"Ordinary Shares","underlying_shares":121476},"source":{"system":"sec-edgar","filing":"0000899243-20-013769","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320013769/doc4.xml","form_type":"4"}},{"id":3140654,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2020-05-20T20:02:34.000Z","date":"2020-05-18","kind":"tax_withholding","acquired":false,"shares":5868,"price":9.67,"value":56743.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represented by ADS."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":86688,"source":{"system":"sec-edgar","filing":"0000899243-20-013769","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320013769/doc4.xml","form_type":"4"}},{"id":3140653,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2020-05-20T20:02:34.000Z","date":"2020-05-18","kind":"exercise","acquired":true,"shares":12144,"price":0.0012,"value":14.5728,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.22 U.S. Dollars as of May 18, 2020."}],"balance_after":92556,"source":{"system":"sec-edgar","filing":"0000899243-20-013769","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320013769/doc4.xml","form_type":"4"}},{"id":3140652,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2020-05-20T20:02:34.000Z","date":"2020-05-18","kind":"tax_withholding","acquired":false,"shares":5868,"price":9.67,"value":56743.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represented by ADS."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":80412,"source":{"system":"sec-edgar","filing":"0000899243-20-013769","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320013769/doc4.xml","form_type":"4"}},{"id":3140651,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2020-05-20T20:02:34.000Z","date":"2020-05-18","kind":"exercise","acquired":true,"shares":121476,"price":0.0012,"value":145.7712,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.22 U.S. Dollars as of May 18, 2020."}],"balance_after":139092,"source":{"system":"sec-edgar","filing":"0000899243-20-013769","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320013769/doc4.xml","form_type":"4"}},{"id":3227102,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2020-03-04T18:01:05.000Z","date":"2020-03-02","kind":"sale","acquired":false,"shares":3420,"price":8.32,"value":28454.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Automatic sale to cover vested restricted stock units that have been previously reported in Column 5 of Table I."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represented by American Depositary Shares of the Issuer (\"ADS\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":79392,"source":{"system":"sec-edgar","filing":"0000899243-20-006993","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320006993/doc4.xml","form_type":"4"}},{"id":3241015,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-28T18:02:35.000Z","date":"2020-02-26","kind":"sale","acquired":false,"shares":180,"price":9.26,"value":1666.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Automatic sale of vested restricted stock units that have been previously reported in Column 5 of Table I."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represented by American Depositary Shares of the Issuer (\"ADS\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":82812,"source":{"system":"sec-edgar","filing":"0000899243-20-006329","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320006329/doc4.xml","form_type":"4"}},{"id":3241014,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-28T18:02:35.000Z","date":"2020-02-26","kind":"sale","acquired":false,"shares":2832,"price":9.17,"value":25969.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Automatic sale of vested restricted stock units that have been previously reported in Column 5 of Table I."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represented by American Depositary Shares of the Issuer (\"ADS\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":82992,"source":{"system":"sec-edgar","filing":"0000899243-20-006329","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320006329/doc4.xml","form_type":"4"}},{"id":3516756,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2019-05-21T20:00:38.000Z","date":"2019-05-18","kind":"exercise","acquired":false,"shares":12144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Vesting of restricted stock units previously reported as stock options on the reporting person's Form 3 filed on October 1, 2018. These ordinary shares are subsequently converted into American Depositary Shares (\"ADS\") of the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.27 U.S. Dollars as of May 17, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The reporting person's Form 3 filed on October 1, 2018 contained stock options to purchase 12,144 ordinary shares vesting on May 18, 2019 and expiring on March 15, 2020. These securities are restricted stock units with a nominal exercise price and vest automatically upon vesting date."}],"balance_after":0,"derivative":{"exercise_price":0.0013,"exercise_date":"2019-05-18","expiration_date":"2019-05-18","underlying":"Ordinary Shares","underlying_shares":12144},"source":{"system":"sec-edgar","filing":"0000899243-19-014292","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319014292/doc4.xml","form_type":"4"}},{"id":3516755,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2019-05-21T20:00:38.000Z","date":"2019-05-20","kind":"sale","acquired":false,"shares":6312,"price":14.76,"value":93165.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price per ordinary share ($177.13 per ADS). These shares were sold in multiple transactions at prices ranging from $177.06 per ADS (or $14.76 per ordinary share) to $177.13 per ADS (or $14.76 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":85824,"source":{"system":"sec-edgar","filing":"0000899243-19-014292","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319014292/doc4.xml","form_type":"4"}},{"id":3516754,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2019-05-21T20:00:38.000Z","date":"2019-05-20","kind":"sale","acquired":false,"shares":5832,"price":14.52,"value":84680.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is price per ordinary share converted from price per ADS."}],"balance_after":92136,"source":{"system":"sec-edgar","filing":"0000899243-19-014292","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319014292/doc4.xml","form_type":"4"}},{"id":3516753,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2019-05-21T20:00:38.000Z","date":"2019-05-18","kind":"exercise","acquired":true,"shares":12144,"price":0.0013,"value":15.7872,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of restricted stock units previously reported as stock options on the reporting person's Form 3 filed on October 1, 2018. These ordinary shares are subsequently converted into American Depositary Shares (\"ADS\") of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.27 U.S. Dollars as of May 17, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 49,632 and 27,456 ordinary shares underlying restricted stock units previously reported as stock options on the reporting person's Form 3 filed on October 1, 2018 and Form 4 filed on March 5, 2019, respectively."}],"balance_after":97968,"source":{"system":"sec-edgar","filing":"0000899243-19-014292","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319014292/doc4.xml","form_type":"4"}},{"id":3611697,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2019-03-05T21:06:38.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":6864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of March 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"These stock options will vest automatically on exercisable date."}],"balance_after":6864,"derivative":{"exercise_price":0.0013,"exercise_date":"2023-03-01","underlying":"Ordinary Shares","underlying_shares":6864},"source":{"system":"sec-edgar","filing":"0000899243-19-006334","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319006334/doc4.xml","form_type":"4"}},{"id":3611696,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2019-03-05T21:06:38.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":6864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of March 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"These stock options will vest automatically on exercisable date."}],"balance_after":6864,"derivative":{"exercise_price":0.0013,"exercise_date":"2022-03-01","underlying":"Ordinary Shares","underlying_shares":6864},"source":{"system":"sec-edgar","filing":"0000899243-19-006334","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319006334/doc4.xml","form_type":"4"}},{"id":3611695,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2019-03-05T21:06:38.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":6864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of March 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"These stock options will vest automatically on exercisable date."}],"balance_after":6864,"derivative":{"exercise_price":0.0013,"exercise_date":"2021-03-01","underlying":"Ordinary Shares","underlying_shares":6864},"source":{"system":"sec-edgar","filing":"0000899243-19-006334","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319006334/doc4.xml","form_type":"4"}},{"id":3611694,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2019-03-05T21:06:38.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":6864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of March 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"These stock options will vest automatically on exercisable date."}],"balance_after":6864,"derivative":{"exercise_price":0.0013,"exercise_date":"2020-03-01","underlying":"Ordinary Shares","underlying_shares":6864},"source":{"system":"sec-edgar","filing":"0000899243-19-006334","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319006334/doc4.xml","form_type":"4"}},{"id":3611693,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2019-03-05T21:06:38.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":91584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of March 1, 2019."}],"balance_after":91584,"derivative":{"exercise_price":0.0013,"exercise_date":"2022-03-01","expiration_date":"2023-03-15","underlying":"Ordinary Shares","underlying_shares":91584},"source":{"system":"sec-edgar","filing":"0000899243-19-006334","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319006334/doc4.xml","form_type":"4"}},{"id":3611692,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2019-03-05T21:06:38.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":48252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"security","element":"securityTitle","label":"F4","text":"The reported options are options to purchase ADSs."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The exercise price reported is price per ordinary share converted from price per ADS ($172.01)."}],"balance_after":48252,"derivative":{"exercise_price":14.33,"exercise_date":"2022-03-01","expiration_date":"2029-03-01","underlying":"Ordinary Shares","underlying_shares":48252},"source":{"system":"sec-edgar","filing":"0000899243-19-006334","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319006334/doc4.xml","form_type":"4"}},{"id":3611691,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2019-03-05T21:06:38.000Z","date":"2019-03-01","kind":"sale","acquired":false,"shares":3732,"price":14.46,"value":53964.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represented by American Depositary Shares of the Issuer (\"ADS\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is price per ordinary share converted from price per ADS."}],"balance_after":8736,"source":{"system":"sec-edgar","filing":"0000899243-19-006334","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319006334/doc4.xml","form_type":"4"}},{"id":3626044,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2019-02-28T17:05:19.000Z","date":"2019-02-26","kind":"exercise","acquired":false,"shares":8436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.29 U.S. Dollars as of February 26, 2019."}],"balance_after":6,"derivative":{"exercise_price":0.0013,"exercise_date":"2019-02-26","expiration_date":"2020-03-15","underlying":"Ordinary Shares","underlying_shares":8436},"source":{"system":"sec-edgar","filing":"0000899243-19-005262","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319005262/doc4.xml","form_type":"4"}},{"id":3626043,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-28T17:05:19.000Z","date":"2019-02-26","kind":"sale","acquired":false,"shares":36,"price":12.29,"value":442.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These ordinary shares are represented by ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is price per ordinary share converted from price per ADS."}],"balance_after":12468,"source":{"system":"sec-edgar","filing":"0000899243-19-005262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319005262/doc4.xml","form_type":"4"}},{"id":3626042,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-28T17:05:19.000Z","date":"2019-02-26","kind":"sale","acquired":false,"shares":3600,"price":12.46,"value":44856.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These ordinary shares are represented by ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is price per ordinary share converted from price per ADS."}],"balance_after":12504,"source":{"system":"sec-edgar","filing":"0000899243-19-005262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319005262/doc4.xml","form_type":"4"}},{"id":3626041,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-28T17:05:19.000Z","date":"2019-02-26","kind":"sale","acquired":false,"shares":504,"price":12.44,"value":6269.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These ordinary shares are represented by ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is price per ordinary share converted from price per ADS."}],"balance_after":16104,"source":{"system":"sec-edgar","filing":"0000899243-19-005262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319005262/doc4.xml","form_type":"4"}},{"id":3626040,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":93697,"kind":"person","name":"Knappertz Volker","position":1,"cik":"0001754122","reported_name":"Knappertz Volker","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-28T17:05:19.000Z","date":"2019-02-26","kind":"exercise","acquired":true,"shares":8436,"price":0.0013,"value":10.9668,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into 703 American Depositary Shares of the Issuer (\"ADS\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.29 U.S. Dollars as of February 26, 2019."}],"balance_after":16608,"source":{"system":"sec-edgar","filing":"0000899243-19-005262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319005262/doc4.xml","form_type":"4"}}]}